top of page

News

Verisian Podcast - March 7, 2025

March 17, 2026

Celebrating Anne. B Sayigh A founding force at Parexel

May 14, 2025

Joe von Rickenbach Joins the Board of Health & Wellness Partners, an NMS Capital Portfolio Company

January 10, 2025

Aileron Therapeutics Announces Rebranding to Rein Therapeutics

October 31, 2023
Aileron Therapeutics Announces Acquisition of Lung Therapeutics

April 12, 2022

Javara Secures Significant Strategic Growth Investment from General Atlantic

December 28, 2021

NextGen Acquisition Corp. II Stockholders Approve Business Combination With Virgin Orbit, the Responsive Launch and Space

July 2, 2021

PAREXEL sold to EQT and Goldman Sachs for $8.5 billion

October 16, 2019

ZAGENO Appoints Josef H. von Rickenbach as Chairman of its Board of Directors

January 29, 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline With Acquisition Of Helio Vision

June 24, 2019

Aileron Therapeutics Strengthens Board of Directors with Appointments of William T. McKee and Josef H. von Rickenbach

May 14, 2018

PAREXEL Co-Founder and Board Chairman Josef von Rickenbach Receives 2018 Ellis Island Medal of Honor

December 13, 2018

PAREXEL Announces Change to Board of Directors

March 5, 2018

PAREXEL co-founder Josef von Rickenbach to end 35-year run as CEO

September 20, 2017

PAREXEL International Acquired by Pamplona Capital Management for Approximately $5 Billion

bottom of page